Daily Stock Analysis, CBMX, CombiMatrix Corp, priceseries

CombiMatrix Corp. Daily Stock Analysis
Stock Information
Open
5.85
Close
5.75
High
5.85
Low
5.50
Previous Close
5.75
Daily Price Gain
0.00
YTD High
6.63
YTD High Date
May 9, 2017
YTD Low
2.60
YTD Low Date
Jan 3, 2017
YTD Price Change
3.00
YTD Gain
109.09%
52 Week High
6.63
52 Week High Date
May 9, 2017
52 Week Low
2.15
52 Week Low Date
Oct 28, 2016
52 Week Price Change
2.59
52 Week Gain
81.96%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Dec 26. 2014
18.45
Jan 14. 2015
22.18
12 Trading Days
20.19%
Link
LONG
Jan 20. 2015
22.95
Feb 11. 2015
28.19
16 Trading Days
22.84%
Link
LONG
Feb 17. 2016
5.88
Feb 18. 2016
6.22
1 Trading Days
5.78%
Link
LONG
Jul 1. 2016
2.98
Jul 26. 2016
3.24
16 Trading Days
8.71%
Link
LONG
Aug 9. 2016
3.65
Aug 10. 2016
3.95
1 Trading Days
8.22%
Link
LONG
Oct 3. 2016
3.08
Oct 4. 2016
3.38
1 Trading Days
9.74%
Link
LONG
Dec 12. 2016
3.00
Dec 14. 2016
3.17
2 Trading Days
5.83%
Link
Company Information
Stock Symbol
CBMX
Exchange
NasdaqCM
Company URL
www.combimatrix.com
Company Phone
949-753-0624
CEO
Mark D. McDonough
Headquarters
California
Business Address
310 GODDARD, SUITE 150, IRVINE, CA 92618
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Laboratories & Research
CIK
0001383183
About

CombiMatrix Corp. engages in the provision of clinical diagnostic services. It offers cytogenomic testing for preimplantation genetic testing, prenatal diagnosis, miscarriage analysis, and pediatric developmental disorders. The company was founded in October 1995 and is headquartered in Irvine, CA.

Description

CombiMatrix Corporation provides molecular diagnostic solutions and clinical support services. It offers DNA-based testing for the detection of genetic abnormalities. The company develops and markets its molecular testing services in the in vitro fertilization, miscarriage analysis, prenatal genetics, and postnatal developmental disorders markets. It provides its services primarily in the area of reproductive health for the diagnosis of developmental disorders associated with intellectual disability, congenital anomalies, dysmorphic features, and autism spectrum disorders. The company serves commercial insurance companies, healthcare institutions, government payors, and individuals. CombiMatrix Corporation was founded in 1995 and is headquartered in Irvine, California.